Numerous studies on HIV-negative participants have identified the utility of elevated AFP in predicting HCC recurrence after initial hepatic resection or other invasive therapy [43,44,45,46] while other investigators have disputed its prognostic role for HCC recurrence [47,48]. Here, AFP is linked to hepatocellular carcinoma.